Monitoring Multidimensional Aspects Of Quality Of Life After Cancer Immunotherapy - An Open Smart Digital Platform For Personalized Prevention And Patient Management

  Address - France

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10118380

  Document Type - Tender Notices

Description - Status : Grant agreement signedOverall budget : € 5 196 772,50EU contribution : € 5 196 772,50"Cancer immunotherapy brought about significant progress in cancer treatment. It resulted in high efficacy in some cancers; e.g., up to 60% objective re sponse rate in melanoma and 80% complete response rate in acute lymphoblastic leukaemia. Nevertheless, two main challenges still impede improving cancer patients’ health status and quality of life (QoL) after immunotherapy initiation: 1) a crucial need for predictive markers of occurrence of immunotherapy-related adverse events (IR-AEs) to predict and improve patients’ health status and promote their QoL; and, 2) the lack of knowledge on pati

Mt Ref Id - 10118380

Deadline - Dec 31, 2023